{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T22:11:13Z","timestamp":1716588673445},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,3,8]],"date-time":"2014-03-08T00:00:00Z","timestamp":1394236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s10067-014-2566-6","type":"journal-article","created":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T06:50:10Z","timestamp":1394175010000},"page":"1685-1688","source":"Crossref","is-referenced-by-count":8,"title":["Hypereosinophilia and Seroconversion of Rheumatoid Arthritis"],"prefix":"10.1007","volume":"33","author":[{"given":"Rachel K.","family":"Rosenstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard S.","family":"Panush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot D.","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,8]]},"reference":[{"issue":"5","key":"2566_CR1","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/art.1780140513","volume":"14","author":"RJ Winchester","year":"1971","unstructured":"Winchester RJ, Koffler D, Litwin SD, Kunkel HG (1971) Observations on the eosinophilia of certain patients with rheumatoid arthritis. Arthritis Rheum 14(5):650\u2013665","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2566_CR2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-75-2-199","volume":"75","author":"RS Panush","year":"1971","unstructured":"Panush RS, Franco AE, Schur PH (1971) Rheumatoid arthritis associated with eosinophilia. Ann Intern Med 75(2):199\u2013205","journal-title":"Ann Intern Med"},{"issue":"2","key":"2566_CR3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/ehm.11.81","volume":"5","author":"P Valent","year":"2012","unstructured":"Valent P, Gleich GJ, Reiter A, Roufosse F, Weller PF, Hellmann A et al (2012) Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field. Expert Rev Hematol 5(2):157\u2013176","journal-title":"Expert Rev Hematol"},{"issue":"5","key":"2566_CR4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/07853890310001339","volume":"35","author":"KK Eklund","year":"2003","unstructured":"Eklund KK, Joensuu H (2003) Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases. Ann Med 35(5):362\u2013367","journal-title":"Ann Med"},{"issue":"6","key":"2566_CR5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.leukres.2008.10.004","volume":"33","author":"N Jain","year":"2009","unstructured":"Jain N, Cortes J, Quintas-Cardama A, Manshouri T, Luthra R, Garcia-Manero G et al (2009) Imatinib has limited therapeutic activity for hypereosinophilic syndrome patients with unknown or negative PDGFR-alpha mutation status. Leuk Res 33(6):837\u2013839","journal-title":"Leuk Res"},{"issue":"1","key":"2566_CR6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0b013e32834d85ce","volume":"24","author":"A Vaglio","year":"2012","unstructured":"Vaglio A, Moosig F, Zwerina J (2012) Churg-Strauss syndrome: update on pathophysiology and treatment. Curr Opin Rheumatol 24(1):24\u201330","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"2566_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00296-004-0469-6","volume":"24","author":"A Kargili","year":"2004","unstructured":"Kargili A, Bavbek N, Kaya A, Kosar A, Karaaslan Y (2004) Eosinophilia in rheumatologic diseases: a prospective study of 1,000 cases. Rheumatol Int 24(6):321\u2013324","journal-title":"Rheumatol Int"},{"issue":"1","key":"2566_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-065X.2011.01026.x","volume":"242","author":"H Kita","year":"2011","unstructured":"Kita H (2011) Eosinophils: multifaceted biological properties and roles in health and disease. Immunol Rev 242(1):161\u2013177","journal-title":"Immunol Rev"},{"issue":"5","key":"2566_CR9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.0954-6820.1979.tb13540.x","volume":"206","author":"G Hillerdal","year":"1979","unstructured":"Hillerdal G, Marjanovic B, Aberg H (1979) Rheumatoid arthritis, immune complex disease, and hypereosinophilic syndrome. Report on a case. Acta Med Scand 206(5):429\u2013432","journal-title":"Acta Med Scand"},{"issue":"6","key":"2566_CR10","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1440-1843.2006.00924.x","volume":"11","author":"M Kudou","year":"2006","unstructured":"Kudou M, Yasuba H, Kobayashi Y, Hamada K, Kita H (2006) Correlation between rheumatoid factor and peripheral eosinophil count in chronic eosinophilic pneumonia. Respirology 11(6):830\u2013832","journal-title":"Respirology"},{"issue":"8","key":"2566_CR11","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/archinte.1978.03630330044012","volume":"138","author":"RK Bush","year":"1978","unstructured":"Bush RK, Geller M, Busse WW, Flaherty DK, Dickie HA (1978) Response to corticosteroids in the hypereosinophilic syndrome. Association with increased serum IgE levels. Arch Intern Med 138(8):1244\u20131246","journal-title":"Arch Intern Med"},{"issue":"4","key":"2566_CR12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaut.2011.08.002","volume":"37","author":"AT Borchers","year":"2011","unstructured":"Borchers AT, Leibushor N, Cheema GS, Naguwa SM, Gershwin ME (2011) Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases. J Autoimmun 37(4):273\u2013288","journal-title":"J Autoimmun"},{"issue":"6","key":"2566_CR13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/ard.2005.044685","volume":"65","author":"P Boura","year":"2006","unstructured":"Boura P, Sarantopoulos A, Lefaki I, Skendros P, Papadopoulos P (2006) Eosinophilic cellulitis (Wells\u2019 syndrome) as a cutaneous reaction to the administration of adalimumab. Ann Rheum Dis 65(6):839\u2013840","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2566_CR14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archderm.142.2.218","volume":"142","author":"H Winfield","year":"2006","unstructured":"Winfield H, Lain E, Horn T, Hoskyn J (2006) Eosinophilic cellulitislike reaction to subcutaneous etanercept injection. Arch Dermatol 142(2):218\u2013220","journal-title":"Arch Dermatol"},{"issue":"3","key":"2566_CR15","first-page":"248","volume":"21","author":"N Cancelliere","year":"2011","unstructured":"Cancelliere N, Barranco P, Vidaurrazaga C, Benito DM, Quirce S (2011) Subacute prurigo and eosinophilia in a patient with rheumatoid arthritis receiving infliximab and etanercept. J Investig Allergol Clin Immunol 21(3):248\u2013249","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"1","key":"2566_CR16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2249.2007.03509.x","volume":"151","author":"S Hutchison","year":"2008","unstructured":"Hutchison S, Choo-Kang BS, Bundick RV, Leishman AJ, Brewer JM, McInnes IB et al (2008) Tumour necrosis factor-alpha blockade suppresses murine allergic airways inflammation. Clin Exp Immunol 151(1):114\u2013122","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"2566_CR17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2222.2008.02958.x","volume":"38","author":"SP Hogan","year":"2008","unstructured":"Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P et al (2008) Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 38(5):709\u2013750","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"2566_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197501000-00001","volume":"54","author":"MJ Chusid","year":"1975","unstructured":"Chusid MJ, Dale DC, West BC, Wolff SM (1975) The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54(1):1\u201327","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2566_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaci.2010.03.042","volume":"126","author":"HU Simon","year":"2010","unstructured":"Simon HU, Rothenberg ME, Bochner BS, Weller PF, Wardlaw AJ, Wechsler ME et al (2010) Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 126(1):45\u201349","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2566_CR20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12185-012-1141-7","volume":"96","author":"M Arefi","year":"2012","unstructured":"Arefi M, Garcia JL, Briz MM, de Arriba F, Rodriguez JN, Martin-Nunez G et al (2012) Response to imatinib mesylate in patients with hypereosinophilic syndrome. Int J Hematol 96(3):320\u2013326","journal-title":"Int J Hematol"},{"issue":"9","key":"2566_CR21","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2002-10-3103","volume":"101","author":"A Pardanani","year":"2003","unstructured":"Pardanani A, Reeder T, Porrata LF, Li CY, Tazelaar HD, Baxter EJ et al (2003) Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders. Blood 101(9):3391\u20133397","journal-title":"Blood"},{"issue":"10","key":"2566_CR22","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1172\/JCI28546.","volume":"116","author":"RT Paniagua","year":"2006","unstructured":"Paniagua RT, Sharpe O, Ho PP, Chan SM, Chang A, Higgins JP et al (2006) Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. J Clin Invest 116(10):2633\u20132642","journal-title":"J Clin Invest"},{"issue":"5","key":"2566_CR23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3109\/s10165-009-0193-x","volume":"19","author":"F Terabe","year":"2009","unstructured":"Terabe F, Kitano M, Kawai M, Kuwahara Y, Hirano T, Arimitsu J et al (2009) Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway. Mod Rheumatol 19(5):522\u2013529","journal-title":"Mod Rheumatol"},{"issue":"5","key":"2566_CR24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/138920009788897975","volume":"10","author":"JT Hartmann","year":"2009","unstructured":"Hartmann JT, Haap M, Kopp HG, Lipp HP (2009) Tyrosine kinase inhibitors\u2014a review on pharmacology, metabolism and side effects. Curr Drug Metab 10(5):470\u2013481","journal-title":"Curr Drug Metab"},{"issue":"4797","key":"2566_CR25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.3105056","volume":"236","author":"P Casali","year":"1987","unstructured":"Casali P, Burastero SE, Nakamura M, Inghirami G, Notkins AL (1987) Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science 236(4797):77\u201381","journal-title":"Science"},{"key":"2566_CR26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0065-2776(08)01006-7","volume":"101","author":"K Takatsu","year":"2009","unstructured":"Takatsu K, Kouro T, Nagai Y (2009) Interleukin 5 in the link between the innate and acquired immune response. Adv Immunol 101:191\u2013236","journal-title":"Adv Immunol"},{"issue":"7280","key":"2566_CR27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature08636","volume":"463","author":"K Moro","year":"2010","unstructured":"Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H et al (2010) Innate production of T (H)2 cytokines by adipose tissue-associated c-Kit (+) Sca-1(+) lymphoid cells. Nature 463(7280):540\u2013544","journal-title":"Nature"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2566-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2566-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2566-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T21:30:16Z","timestamp":1716586216000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2566-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,8]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["2566"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2566-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,8]]}}}